We provide tailor-made advice in a wide range of transactions including mergers and acquisitions, divestitures, leveraged buyouts and capital increases. We cover all sectors, advising family businesses, financial investors and corporates.
With a flexible approach, we co-invest alongside top tier private equity funds and acquire minority stakes. Over the years we have built a diversified portfolio of leading Italian companies in their reference sectors.Current investments: Biofarma, Mipharm, Treedom, Hippocrates, Alpha Test, Golden Goose, Freeda, Liberi Reggiomonte, Dolciaria Acquaviva, Enoflex Group, Design Holding, Indo, River Group, Irca, Zushi and Cellularline
ACQUISITION OF
BY
M&A AdvisoryMay 2022
ACQUISITION OF
BY
Equity InvestmentApril 2022
ACQUISITION OF
BY
Equity InvestmentMarch 2022
ACQUISITION OF
FROM
M&A AdvisoryDecember 2021
ACQUISITION OF
FROM
M&A AdvisoryDecember 2021
ACQUISITION OF A MINORTY STAKE
Equity InvestmentJune 2021
Ergon acquires Dolciaria Acquaviva
Cobepa acquires Enoplastic
Alto Partners invests in Olimpia Splendid
Investindustrial and Carlyle create Design Holding
Ergon acquires Indo
Consilium SGR acquires River Group
Hennecke acquires OMS Group
Finance Community Awards
Bluegem acquires Dr. Vranjes
The Carlyle Group acquires Irca